Results 111 to 120 of about 10,141,888 (301)
Systemic Extracerebral Atherosclerotic Burden and Dementia Risk After Incident Stroke
ABSTRACT Background Stroke survivors are at increased risk of dementia, but clinically accessible markers of risk heterogeneity remain limited. Previous studies have largely examined atherosclerotic disease in individual vascular beds rather than the overall burden of systemic extracerebral atherosclerosis.
Zhexuan Yu +4 more
wiley +1 more source
Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s [PDF]
Internationalisation is a useful strategy to gain firm specific advantages during periods of technological discontinuity. The pharmaceutical industry offers us two such episodes as examples: when the antibiotics revolution was beginning and when the ...
Athreye, Suma, Godley, Andrew
core
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Journal of Advanced Pharmaceutical Technology and Research
Upendra Nagaich
doaj +4 more sources
Nia Yuniarsih,1,2 Anis Yohana Chaerunisaa,3 Ahmed Fouad Abdelwahab Mohammed,4,5 Khaled M Elamin,6 Muchtaridi Muchtaridi,7 Nasrul Wathoni31Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Padjadjaran University, Sumedang ...
Yuniarsih N +5 more
doaj
Factors affecting technology commercialization in Iranian knowledge based pharmaceutical companies
Background: Looking at the performance of the Iranian knowledge based pharmaceutical companies in recent years shows that, despite extensive capabilities in technological development, many companies involved in technology commercialization have been ...
Ramin Radmanesh, Abbas Kebriaeezadeh
doaj
Objective For cartilage morphology to serve as a scalable endpoint in clinical trials, analyses should be performed automatically without human interaction. To clinically validate artificial intelligence (AI)‐based analysis, we studied cartilage loss from MRI prior to knee replacement.
Felix Eckstein +3 more
wiley +1 more source
Systems integration in pharmaceutical industry using object-oriented expert system technology [PDF]
SPHINX is an object-oriented expert system addressed to solve the burning problems of pharmaceutical industry. SPHINX stands for Systems integration in PHarmaceutical INdustry using object-oriented eXpert system technology. Various problems that American
Reddy, Korrapolu
core +1 more source

